The World Health Organization (WHO) has said it is awaiting regulatory reviews of the Janssen Covid-19 vaccine after US health authorities said the jab should be suspended due to rare blood clotting among some recipients. “We're watching closely, waiting for EMA (European Medicines Agency) and FDA (U.S. Food and Drug Administration) reviews and monitoring the global database of adverse event reports to see if there have been cases anywhere else,” the WHO said in a statement to Reuters. On Tuesday, the FDA announced the suspension of the Johnson & Johnson's Janssen jab after it reported six cases of cerebral venous sinus thrombosis (CVS
Hence then, the article about who awaiting j j covid vaccine reviews as us suspension prompts drug maker to delay europe rollout amid blood clot fears was published today ( ) and is available onRussia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( WHO ‘awaiting’ J&J Covid vaccine reviews as US suspension prompts drug maker to delay Europe rollout amid blood clot fears )